Ligand · E3Q
E3Q · 1-cycloheptyl-3-{4-methoxy-3-[(2-methoxyphenyl) methoxy]phenyl}-4,4-dimethyl-4,5-dihydro- 1H-pyrazol-5-one
E3Q, 1-cycloheptyl-3-{4-methoxy-3-[(2-methoxyphenyl) methoxy]phenyl}-4,4-dimethyl-4,5-dihydro- 1H-pyrazol-5-one (C27 H34 N2 O4, 450.6 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (2 PDB entries). Every binding site…
- Component
- E3Q
- Formula
- C27 H34 N2 O4
- Class
- ligand
- Structures
- 2
- PDB entries
- 2
Binding sites
E3Q in 2 structures; the first of them:
- 6FRD · Crystal structure of T. brucei pde-B1 catalytic domain with inhibitor npd-637 · E3Q B1006 · binds MET785, ILE823, ASN825, ALA837, VAL840, THR841, PHE844, MET861 and 4 more
- 6IAG · Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor npd-637 · E3Q A513 · binds TYR159, HIS160, MET273, LEU319, ASN321, ILE336, MET337, PHE340 and 4 more
Residues it binds most
MET 5, PHE 5, ILE 5, ASN 5, GLN 5, LEU 5, HIS 4, SER 4, TYR 2, ALA 1 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.